[Federal Register Volume 61, Number 78 (Monday, April 22, 1996)]
[Notices]
[Page 17705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9778]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Joan Gans, R.N., Denver Department of Health and Hospitals: Based 
on an audit of records conducted by the National Institute of Allergy 
and Infectious Diseases (NIAID) and Ms. Gans admission, ORI found that 
Joan Gans, R.N., while employed at the Denver Community Program for 
Clinical Research on AIDS at the Department of Public Health, Denver 
Department of Health and Hospitals, committed scientific misconduct by 
falsifying and fabricating data related to patients entered on clinical 
trials. The research was supported by a NIAID contract.
    Ms. Gans has entered into a Voluntary Exclusion Agreement with ORI 
in which she has voluntarily agreed:
    (1) To exclude herself from any contracting or subcontracting with 
any agency of the United States Government and from eligibility for, or 
involvement in, nonprocurement transactions (e.g., grants and 
cooperative agreements) of the United States Government, as defined in 
45 CFR Part 76 (Debarment Regulations) for a period of two (2) years 
beginning April 4, 1996;
    (2) That for a period of one (1) year immediately following the two 
(2) year voluntary exclusion above, any institution that submits an 
application for Public Health Service (PHS) support for a research 
project on which Ms. Gans' participation is proposed or that uses her 
in any capacity in PHS supported research must concurrently submit a 
plan for supervision of her duties; the supervisory plan must be 
designed to ensure the scientific integrity of Ms. Gans' research 
contribution, and the institution must submit a copy of the plan to 
ORI; and
    (3) To exclude herself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant for 
a period of three (3) years beginning April 4, 1996.
    The above voluntary exclusion, however, shall not apply to Ms. 
Gans' future training or practice of clinical nursing whether as a 
nursing student, resident, fellow, or licensed nurse, as the case may 
be, unless that practice involves research or research training.
    No scientific publications were required to be corrected as part of 
this Agreement. The questioned data will be excluded before any 
findings of the affected clinical trials are reported.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 5515 Security Lane, Suite 
700, Rockville, MD 20852.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 96-9778 Filed 4-19-96; 8:45 am]
BILLING CODE 4160-17-P